Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **ciliary body** is a ring-like structure in the anterior segment of the eye, located between the iris and the choroid. It consists of three main components: the ciliary muscle, which controls lens accommodation for focusing; the ciliary processes, which secrete the aqueous humor that maintains intraocular pressure and nourishes avascular tissues; and the ciliary epithelia, a bilayer of pigmented and non-pigmented cells involved in fluid and metabolic exchange. Dysfunction or pathology of the ciliary body is involved in diseases such as glaucoma, and therapies for elevated intraocular pressure may target ciliary body function—typically by reducing aqueous humor production or destroying part of the ciliary epithelium. However, it is not a drug target in the sense of being a single molecular entity such as a receptor or enzyme.
Inhibition of aqueous humor secretion Destruction/ablation of ciliary epithelium to reduce intraocular pressure
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ciliary body (None).